Researchers investigated the ability of a recombinant BTN2A2-IgG2a Fc fusion protein to treat Collagen type II (CIA). They showed that administration of BTN2A2-Ig attenuatex established CIA, as compared with control Ig protein treatment.
[Scientific Reports]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
167331
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
